Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 3/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.48 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.48 |
| ▸ | GSR | P00390 | 2/20 | 0.48 |
| ▸ | GRM8 | O00222 | 1/20 | 0.48 |
| ▸ | GRM6 | O15303 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.48 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.48 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.48 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.48 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.48 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.48 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.48 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.48 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3289233 | 1.00 | SLC1A1 (0.48) | SLC1A1GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL15509381 | 0.87 | GSTP1 (0.41) | SLC1A1GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL1661419 | 0.87 | GSTP1 (0.41) | SLC1A1GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL28063444 | 0.85 | GSTP1 (0.38) | SLC1A1GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL4230332 | 0.82 | SLC1A2 (0.48) | SLC1A1GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL3289350 | 0.81 | GRIK1 (0.47) | SLC1A1GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL29410188 | 0.79 | GSR (0.46) | SLC1A1GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL28945063 | 0.79 | GSR (0.46) | SLC1A1GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL10453103 | 0.77 | GSR (0.56) | SLC1A1GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL1064949 | 0.77 | SLC1A1 (0.56) | SLC1A1GRIK1GRIK2SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115010919-B | Polypeptide, nano switch based on polypeptide, and preparation method and application of nano switch | 苏州大学 | 2023-11-24 | — | — | CN | disclosed |
| CN-115364240-A | Gate-controlled nanoparticle based on polypeptide and preparation method and application thereof | 苏州大学 | 2022-11-22 | — | — | CN | disclosed |
| US-20170079928-A1 | COPOLYMERS OF FORMULA (I) AND USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) | 2017-03-23 | — | — | US | disclosed |
| US-20170079928-A1 | COPOLYMERS OF FORMULA (I) AND USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) | 2017-03-23 | — | — | US | disclosed |
| WO-2015181504-A1 | COPOLYMERS OF FORMULA (I) AND USES | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES (FR) | 2015-12-03 | — | — | WO | disclosed |
| EP-2493868-A2 | POLY(PROPARGYL-L-GLUTAMATE) AND DERIVATIVES THEREOF | Massachusetts Institute Of Technology (US) | 2012-09-05 | — | — | EP | disclosed |
| US-8222359-B2 | Poly(propargyl-L-glutamate) and derivatives thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-07-17 | — | — | US | disclosed |
| WO-2011056645-A2 | POLY(PROPARGYL-L-GLUTAMATE) AND DERIVATIVES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-05-12 | — | — | WO | disclosed |
| US-20110097419-A1 | Poly(Propargyl-L-Glutamate) and Derivatives Thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110097419-A1 | Poly(Propargyl-L-Glutamate) and Derivatives Thereof | GLUL, QPCTL, QPCT | SLC1A1 105/4885GRIK1 36/4885GRIK2 47/4885 |
| US-20170079928-A1 | COPOLYMERS OF FORMULA (I) AND USES | MSR1, ASGR1, FCGR3B | SLC1A1 2587/4885GRIK1 339/4885GRIK2 903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.